Deutsch English Français

Contact

EP1084705

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1084705

EP1084705 - Method for lowering blood glucose levels in mammals [Right-click to bookmark this link]
Status	Opposition procedure closed Status updated on 16.10.2015 Database last updated on 20.11.2024
Most recent event Tooltip	01.11.2019	Change - lapse in a contracting state	published on 04.12.2019 [2019/49]
Applicant(s)	For all designated states Royalty Pharma Collection Trust Rodney Square North 1100 North Market Street Wilmington DE 19890 / US
	[2014/26]
Former [2012/07]	For all designated states Royalty Pharma Collection Trust Rodney Square North 1100 North Market Street Wilmington DE 19890 / US
Former [2011/38]	For all designated states Royalty Pharma Finance Trust Rodney Square North 1100 North Market Street Wilmington DE 19890 / US
Former [2004/44]	For all designated states Prosidion Limited Windrush Court Watlington Road Oxford, OX4 6LT / GB
Former [2002/27]	For all designated states Probiodrug AG Weinbergweg 22 06120 Halle/Saale / DE
Former [2001/12]	For all designated states Probiodrug Gesellschaft für Arzneimittelforschung mbH Weinbergweg 22, Biozentrum 06120 Halle/Saale / DE
Inventor(s)	01 / Demuth, Hans-Ulrich Hegelstrasse 14 06114 Halle / DE
	02 / Rosche, Fred Benndorfer Strasse 18a 06184 Dieskau / DE
	03 / Schmidt, Jörn Eichendorffstrasse 2 06114 Halle / DE
	04 / Pauly, Robert P., Dr., @Walter McKenzie Centre Dept. of Medicine 2 Fl. 12 8440 112 Street Edmonton, AB T6G 2B7 / CA
	05 / McIntosh, Christopher H.S. 605-2233 Allison Road Vancouver, B.C. V6T 1T7 / CA
	06 / Pederson, Ray A. 3876 West 23rd Avenue Vancouver, B.C. V6S 1K9 / CA
	[2014/26]
Former [2001/18]	01 / Demuth, Hans-Ulrich Hegelstrasse 14 06114 Halle / DE
	02 / Rosche, Fred Benndorfer Strasse 18a 06184 Dieskau / DE
	03 / Schmidt, Jörn Eichendorffstrasse 2 06114 Halle / DE
	04 / Pauly, Robert P., Dr., Walter McKenzie Centre Dept. of Medicine, 2 Fl. 12, 8440 112 Street Edmonton, AB T6G 2B7 / CA
	05 / McIntosh, Christopher H.S. 605-2233 Allison Road Vancouver, B.C. V6T 1T7 / CA
	06 / Pederson, Ray A. 3876 West 23rd Avenue Vancouver, B.C. V6S 1K9 / CA
Former [2001/12]	01 / Demuth, Hans-Ulrich Hegelstrasse 14 06114 Halle / DE
	02 / Rosche, Fred Benndorfer Strasse 18a 06184 Dieskau / DE
	03 / Schmidt, Jörn Eichendorffstrasse 2 06114 Halle / DE
	04 / Pauly, Robert P. 2631 Fairview Crescent Vancouver, B.C. V6T 2B8 / CA
	05 / McIntosh, Christopher H.S. 605-2233 Allison Road Vancouver, B.C. V6T 1T7 / CA
	06 / Pederson, Ray A. 3876 West 23rd Avenue Vancouver, B.C. V6S 1K9 / CA
Representative(s)	Bühler, Dirk Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE
	[N/P]
Former [2014/08]	Bühler, Dirk Maiwald Patentanwalts GmbH Elisenhof Elisenstraße 3 80335 München / DE
Former [2013/15]	Mintz Levin Cohn Ferris Glovsky and Popeo LLP Alder Castle 10 Noble Street London EC2V 7JX / GB
Former [2011/38]	Crump, Julian Richard John, et al Mintz Levin Cohn Ferris Glovsky & Popeo Intellectual Property LLP Alder Castle 10 Noble Street London EC2V 7JX / GB
Former [2011/26]	Talbott, Dawn Jacqueline, et al Prosidion Limited Windrush Court Watlington Road Oxford OX4 6LT / GB
Former [2010/38]	Crump, Julian Richard John, et al Mintz Levin Cohn Ferris Glovsky & Popeo Intellectual Property LLP Alder Castle 10 Noble Street London EC2V 7JX / GB
Former [2010/35]	Blakey, Alison Jane, et al Prosidion Limited Windrush Court Watlington Road Oxford Oxfordshire OX4 6LT / GB
Former [2004/44]	Blakey, Alison Jane Prosidion Limited Windrush Court Watlington Road Oxford OX4 6LT / GB
Former [2001/12]	Forstmeyer, Dietmar, Dr. rer. nat., Dipl.-Chem., et al Boeters & Bauer, Bereiteranger 15 81541 München / DE
Application number, filing date	00119496.8	24.04.1997
	[2001/12]
Priority number, date	DE19961016486	25.04.1996 Original published format: DE 19616486
	[2001/12]
Filing language	DE
Procedural language	DE
Publication	Type:	A2 Application without search report
	No.:	EP1084705
	Date:	21.03.2001
	Language:	DE
	[2001/12]
	Type:	A3 Search report
	No.:	EP1084705
	Date:	15.05.2002
	[2002/20]
	Type:	B1 Patent specification
	No.:	EP1084705
	Date:	25.06.2014
	Language:	DE
	[2014/26]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	03.04.2002
Classification	IPC:	A61K31/00, A61K31/401, A61P3/10, A61K31/40, A61K31/426	[2014/20]
	CPC:	A61K31/401 (EP,US); A61K31/425 (KR); A61K31/00 (EP,US); A61K31/40 (EP,US); A61K31/426 (EP,US); A61P3/00 (EP); (+) A61P3/06 (EP); A61P3/08 (EP); A61P3/10 (EP); A61P3/12 (EP); A61P43/00 (EP); A61P5/50 (EP) (-)
	Former IPC [2002/20]	A61K31/426, A61K38/05, A61K31/40, A61K31/235, A61P3/10
	Former IPC [2001/12]	A61K31/425
Designated contracting states	AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/12]
Extension states	AL	18.09.2000
	LT	18.09.2000
	LV	18.09.2000
	RO	18.09.2000
	SI	18.09.2000
Title	German:	Verfahren zur Senkung des Blutglukosespiegels in Säugern	[2001/12]
	English:	Method for lowering blood glucose levels in mammals	[2001/12]
	French:	Méthode pour diminuer le taux de glucose sanguin des mammifères	[2001/12]
Examination procedure	18.09.2000	Examination requested [2001/12]
	17.12.2003	Despatch of a communication from the examining division (Time limit: M10)
	07.02.2005	Reply to a communication from the examining division
	07.04.2010	Despatch of a communication from the examining division (Time limit: M06)
	19.11.2010	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	27.01.2011	Reply to a communication from the examining division
	08.07.2011	Despatch of a communication from the examining division (Time limit: M21)
	17.04.2013	Reply to a communication from the examining division
	02.04.2014	Date of oral proceedings
	06.05.2014	Minutes of oral proceedings despatched
	12.05.2014	Communication of intention to grant the patent
	14.05.2014	Fee for grant paid
	14.05.2014	Fee for publishing/printing paid
	14.05.2014	Receipt of the translation of the claim(s)
Parent application(s) Tooltip	EP97924866.3 / EP0896538
Divisional application(s)	EP10184503.0 / EP2289513
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19970924866) is 16.10.2000
Opposition(s)	Opponent(s)	01 25.03.2015 02.09.2015 WITHDRAWN Generics [UK] Limited (trading as Mylan) Albany Gate Darkes Lane Potters Bar Hertfordshire EN6 1AG / GB Opponent's representative Handley, Matthew Edward, et al, et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB
		[2015/42]
	Former [2015/18]
	Opponent(s)	01 25.03.2015 WITHDRAWN Generics [UK] Limited (trading as Mylan) Albany Gate Darkes Lane Potters Bar Hertfordshire EN6 1AG / GB Opponent's representative Handley, Matthew Edward, et al, et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB
	30.04.2015	Invitation to proprietor to file observations on the notice of opposition
	02.09.2015	Legal effect of closure of opposition procedure [ N /P ]
	02.09.2015	Legal effect of closure of opposition procedure [2015/47]
	15.09.2015	Reply of patent proprietor to notice(s) of opposition
	12.10.2015	Despatch of communication that the opposition procedure will be closed
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	27.01.2011	Request for further processing filed
	27.01.2011	Full payment received (date of receipt of payment) Request granted
	11.02.2011	Decision despatched
	07.02.2005	Request for further processing filed
	07.02.2005	Full payment received (date of receipt of payment) Request granted
	18.02.2005	Decision despatched
Fees paid	Renewal fee
	18.09.2000	Renewal fee patent year 03
	18.09.2000	Renewal fee patent year 04
	25.04.2001	Renewal fee patent year 05
	25.04.2002	Renewal fee patent year 06
	29.04.2003	Renewal fee patent year 07
	27.04.2004	Renewal fee patent year 08
	02.05.2005	Renewal fee patent year 09
	02.05.2006	Renewal fee patent year 10
	02.05.2007	Renewal fee patent year 11
	02.05.2008	Renewal fee patent year 12
	04.05.2009	Renewal fee patent year 13
	03.05.2010	Renewal fee patent year 14
	06.04.2011	Renewal fee patent year 15
	06.03.2012	Renewal fee patent year 16
	12.04.2013	Renewal fee patent year 17
	31.03.2014	Renewal fee patent year 18
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Former [2015/52]	LU	24.04.2015
Former [2015/26]	deleted
Former [2015/12]	NL	25.06.2014
Documents cited:	Search	[A]WO9117767 (NEW ENGLAND MEDICAL CENTER INC [US], et al) [A] * page 1, paragraph 2 *;
		[XY]EP0708179 (LILLY CO ELI [US]) [X] 1-6,8 * page 2, line 26 - page 3, line 25 * [Y] 7;
		[XY] - MENTLEIN ROLF ET AL, "Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)-amide, peptide histidine methionine and is responsible for their degradation in human serum.", EUROPEAN JOURNAL OF BIOCHEMISTRY, (1993), vol. 214, no. 3, ISSN 0014-2956, pages 829 - 835, XP000921372 [X] 1-6,8 * page 830, column 1, paragraph 1 * * page 833, column 2, paragraph 2 - paragraph 4 * [Y] 7 DOI: http://dx.doi.org/10.1111/j.1432-1033.1993.tb17986.x
		[Y] - ENDROCZI, E. ET AL, "Dipeptidyl peptidase IV (DP IV) and superoxide dismutase activity in thymus-derived lymphocytes: effects of inhibitory peptides and zinc in vitro", ACTA PHYSIOL. HUNG. (1990), 75(1), 35-44, XP008000941 [Y] 7 * page 36, paragraph 3 - paragraph 5 * * page 42, paragraph 3 *
		[A] - ASHWORTH, DOREEN M. ET AL, "2-Cyanopyrrolidides as potent, stable inhibitors of dipeptidyl peptidase IV", BIOORG. MED. CHEM. LETT. (1996), 6(10), 1163-1166, XP000957893 [A] * page 1163, paragraph 3 * DOI: http://dx.doi.org/10.1016/0960-894X(96)00190-4

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p